Guggenheim Capital’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-23,898
| Closed | -$368K | – | 1651 |
|
|
2025
Q4 | $368K | Sell |
23,898
-24,366
| -50% | -$268K | ﹤0.01% | 1435 |
|
|
2025
Q3 | $479K | Buy |
48,264
+794
| +2% | +$8.26K | ﹤0.01% | 1200 |
|
|
2025
Q2 | $471K | Buy |
47,470
+4,005
| +9% | +$42.2K | ﹤0.01% | 1218 |
|
|
2025
Q1 | $564K | Sell |
43,465
-3,604
| -8% | -$47.7K | 0.01% | 1147 |
|
|
2024
Q4 | $601K | Sell |
47,069
-23,029
| -33% | -$279K | ﹤0.01% | 1181 |
|
|
2024
Q3 | $781K | Buy |
70,098
+4,246
| +6% | +$46.8K | 0.01% | 1213 |
|
|
2024
Q2 | $740K | Sell |
65,852
-51,263
| -44% | -$597K | 0.01% | 1258 |
|
|
2024
Q1 | $1.45M | Buy |
117,115
+782
| +0.7% | +$10.2K | 0.01% | 1025 |
|
|
2023
Q4 | $1.63M | Buy |
116,333
+57,605
| +98% | +$800K | 0.01% | 933 |
|
|
2023
Q3 | $867K | Buy |
58,728
+6,833
| +13% | +$96.1K | 0.01% | 1165 |
|
|
2023
Q2 | $670K | Buy |
51,895
+36,264
| +232% | +$413K | 0.01% | 1333 |
|
|
2023
Q1 | $153K | Sell |
15,631
-10,921
| -41% | -$117K | ﹤0.01% | 1840 |
|
|
2022
Q4 | $283K | Buy |
26,552
+752
| +3% | +$8.74K | ﹤0.01% | 1690 |
|
|
2022
Q3 | $269K | Sell |
25,800
-29,189
| -53% | -$380K | ﹤0.01% | 1696 |
|
|
2022
Q2 | $692K | Buy |
+54,989
| New | +$584K | 0.01% | 1409 |
|
|
2018
Q4 | – | Sell |
-138,719
| Closed | -$1.72M | – | 2216 |
|
|
2018
Q3 | $1.72M | Buy |
138,719
+19,383
| +16% | +$262K | 0.01% | 1325 |
|
|
2018
Q2 | $1.82M | Buy |
119,336
+7,058
| +6% | +$122K | 0.01% | 1307 |
|
|
2018
Q1 | $2.23M | Buy |
112,278
+7,522
| +7% | +$130K | 0.01% | 1556 |
|
|
2017
Q4 | $1.96M | Sell |
104,756
-4,283
| -4% | -$86K | ﹤0.01% | 1687 |
|
|
2017
Q3 | $2.35M | Buy |
+109,039
| New | +$1.73M | 0.01% | 1549 |
|
|
2014
Q4 | – | Sell |
-1,933
| Closed | -$28K | – | 3031 |
|
|
2014
Q3 | $28K | Sell |
1,933
-161
| -8% | -$2.32K | ﹤0.01% | 2955 |
|
|
2014
Q2 | $34K | Sell |
2,094
-117
| -5% | -$1.76K | ﹤0.01% | 3119 |
|
|
2014
Q1 | $40K | Sell |
2,211
-78
| -3% | -$1.45K | ﹤0.01% | 3162 |
|
|
2013
Q4 | $45K | Buy |
2,289
+37
| +2% | +$542 | ﹤0.01% | 3066 |
|
|
2013
Q3 | $27K | Buy |
2,252
+622
| +38% | +$7.83K | ﹤0.01% | 2997 |
|
|
2013
Q2 | $18K | Buy |
+1,630
| New | +$34.3K | ﹤0.01% | 2992 |
|
Other funds holding DVAX
Guggenheim Capital's DVAX Position: Q1 2026 in Review
Guggenheim Capital sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 23,898 shares — an estimated $368K sold.
Guggenheim Capital first reported a position in DVAX in Q2 2013 and held it in 26 quarters. The position peaked at $2.35M in Q3 2017. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Guggenheim Capital reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Guggenheim Capital sold 23,898 Dynavax Technologies shares in Q1 2026, an estimated $368K.
- Guggenheim Capital first reported a position in Dynavax Technologies in Q2 2013 and held it in 26 quarters.
- Guggenheim Capital's Dynavax Technologies position peaked at $2.35M in Q3 2017.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.